VentriPoint Diagnostics Ltd.

Receive alerts
Market Cap:
$6.8 m
52 weeks high
52 weeks low

Filter by article type

Viewing results 1-25 of 78


Ventripoint Diagnostics has groundbreaking new device to help combat heart disease

The Ventripoint Medical System is the only approved way to generate substantially equivalent results to gold-standard MRI ...

1 week, 2 days ago

Ventripoint Diagnostics to bring its cardiac-imaging technology to France

France-based Irudigi will help bring to market Ventripoint's VMS+ device that uses AI to measure the whole heart with conventional ultrasound...

on 15/5/19

Ventripoint Diagnostics shares rise as it gains major customer for complete heart analysis system

The University of Ottawa Heart Institute, Canada’s largest heart health centre, will use Ventripoint’s system to assess cardiac patients...

on 25/3/19

Ventripoint showcases its latest VMS+3.0 cardio-monitoring system at American College of Cardiology's 68th Annual conference

VMS+3.0 is Ventripoint's newest version of its machine, which revolutionizes the way doctors treat heart patients as it gives accurate and rapid volumetric information on all four chambers of the heart...

on 19/3/19

Ventripoint Diagnostics' stock rockets after VMS System approved for sale, clinical use in China

CEO George Adams said 32,000 hospitals in China would now have access to a 2D ultrasound analytical system to accurately assess right-heart function...

on 5/3/19

Ventripoint Diagnostics reports progress for latest VMS +3.0 heart monitoring system

VMS is a machine, which revolutionizes the way doctors treat heart patients as it can give accurate and rapid volumetric information about all four chambers of the heart...

on 5/2/19

Ventripoint Diagnostics awarded medical device single audit program certification

The firm is behind the VMS Plus, an accurate AI (artificial intelligence) tool for measuring whole heart function ...

on 22/1/19

Ventripoint Diagnostics increases placing to $1.5M due to demand

The proceeds will be used for sales and marketing, development and general working capital...

on 21/1/19

Ventripoint Diagnostics arranges C$1M private placement of debenture units

Proceeds will be used for sales and marketing, development and general working capital ...

on 9/1/19

Ventripoint Diagnostics shares pump after positive findings from sarcoidosis study in Netherlands using VMS

Pulmonary hypertension occurs in 6% to 74% of patients with sarcoidosis ......

on 7/1/19

Ventripoint says Johns Hopkins doctor cited VMS+ heart analysis system’s clinical feasibility at Milan conference

Dr Shelby Kutty gave a presentation on a study conducted at the University of Nebraska Medical Center Children's Hospital...

on 14/12/18

VentriPoint Diagnostics to showcase its VMS Plus heart system at Milan conference

The event has nearly 4,000 healthcare professionals from over 90 countries around the world...

on 29/11/18

VentriPoint Diagnostics reports that its new approved heart technology being used by internationally renowned pediatric cardiologist

Earlier this week, the firm said its VMS+ software had been approved for analyzing 3D echo images...

on 20/11/18

VentriPoint Diagnostics says its innovative heart machine can also analyse 3D echo images

The medtech group said that its VMS+ software approved for analysis of all four chambers of the heart can be used for the analysis of 3D echo images...

on 19/11/18

VentriPoint Diagnostics' heart monitoring tech further boosted by agreement with Canadian government

The goal of the program is to extend the visualization extracted from 2D ultrasound images and visualize 4D images...

on 14/11/18

VentriPoint Diagnostics receives order for its VMS Plus - from leading cardiac hospital in Toronto

The VMS+ system uses standard 2D echocardiogram images and Artificial Intelligence (AI)...

on 12/11/18

VentriPoint Diagnostics reveals that University of Chicago will assess its heart analysis system

Dr Lang is an internationally renowned cardiologist and specialist in echocardiography.....

on 5/11/18

VentriPoint Diagnostics shares tick higher as it hires new marketing manager

The firm's VMS Plus device is an accurate AI (artificial intelligence) tool for measuring whole-heart function...

on 18/10/18

VentriPoint Diagnostics brings in over C$1mln from placing; closes second tranche

The group issued around 2.43mln units at C$0.21 each for gross proceeds of $511,499.94...

on 14/9/18

VentriPoint Diagnostics closes C$500,000 first tranche of financing

On August 15, the group said it was set for a C$1mln placing to be used for sales and marketing...

on 5/9/18

VentriPoint Diagnostics set for C$1mln raise

The group is set for a C$1mln private placing to be used for sales and marketing, among others . ...

on 15/8/18

VentriPoint Diagnostics updates on AI collaboration

In March this year, the firm reported on its collaboration with Ryerson University...

on 13/8/18

VentriPoint rises as it announces prototype of VMS-plus 3.0

Ventripoint's technology is a leading artificial intelligence approach known as knowledge-based reconstruction, used to create applications to monitor heart disease...

on 8/8/18